Purinol 300mg Tablets

Страна: Ірландія

мова: англійська

Джерело: HPRA (Health Products Regulatory Authority)

купити це зараз

Активний інгредієнт:

Allopurinol

Доступна з:

Pinewood Laboratories Ltd,

Код атс:

M04AA; M04AA01

ІПН (Міжнародна Ім'я):

Allopurinol

Дозування:

300 milligram(s)

Фармацевтична форма:

Tablet

Тип рецепту:

Product subject to prescription which may be renewed (B)

Терапевтична области:

Preparations inhibiting uric acid production; allopurinol

Статус Авторизація:

Not marketed

Дата Авторизація:

1982-11-01

інформаційний буклет

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
Purinol 100 mg and 300 mg Tablets
Allopurinol
24LF
Read all of this leaflet carefully before you start taking this
medicine because it contains important information for you.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their symptoms are the same as
yours.
•
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
What is in this leaflet
1.
What Purinol Tablets are and what they are used for
2.
What you need to know before you take Purinol Tablets
3.
How to take Purinol Tablets
4.
Possible side effects
5.
How to store Purinol Tablets
6.
Contents of the pack and other information
1.
What Purinol Tablets are and what they are used for
Purinol Tablets contain the active ingredient allopurinol, this
belongs to a group of medicines called xanthine oxidase inhibitors,
which act to control the
speed at which certain chemical changes occur in the body.
Purinol tablets are used to treat conditions in which there is too
much uric acid in the body such as:
•
gout
•
certain types of kidney disease and kidney stones
•
cancer and some enzyme disorders which lead to the build up of uric
acid (symptoms may include swelling and inflammation of the joints).
2.
What you need to know before you take Purinol Tablets
Do NOT take Purinol Tablets if you:
•
have had an allergic reaction to Purinol, allopurinol or any of the
other ingredients (see section 6 and end of section 2)
Warnings and precautions
Talk to your doctor or pharmacist before taking Purinol Tablets if:
•
you are suffering, or suffered from liver or kidney disease
•
you are taking medicines for heart disease or high blood pressure,
e.g. diuretics (water tablets) or ACE inhibitors
•
you are experiencing an acute attack of gout
•
you are of Han Chin
                                
                                Прочитайте повний документ
                                
                            

Характеристики продукта

                                HealthProductsRegulatoryAuthority
27February2019
CRN008WVT
Page1of12
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Purinol300mgTablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Eachtabletcontains300mgAllopurinol
Excipients:Eachtabletcontains180mglactosemonohydrate.
_For a full list of excipients, see section 6.1_
3 PHARMACEUTICAL FORM
Tablet
White,biconvextablet,engraved2K1,plainonthereverse.
Thescorelineisonlytofacilitatebreakingforeaseofswallowing
andnottodivideintoequaldoses.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Allopurinolisindicatedforreducingurate/uricacidformationinconditionswhereurate/uricaciddepositionhasalready
occurred(e.g.goutyarthritis,skintophi,nephrolithiasis)orisapredictableclinicalrisk(e.g.treatmentofmalignancypotentially
leadingtoacuteuricacidnephropathy).
Themainclinicalconditionswhereurate/uricaciddepositionmayoccurare:

idiopathicgout;

uricacidlithiasis;

acuteuricacidnephropathy;

neoplasticdiseaseandmyeloproliferativediseasewithhighcellturnoverrates,inwhichhighuratelevelsoccur
eitherspontaneously,oraftercytotoxictherapy;

certainenzymedisorderswhichleadtooverproductionofurate,forexample:
-
hypoxanthine-guaninephosphoribosyltransferase,includingLesch-Nyhansyndrome;
-
glucose-6-phosphataseincludingglycogenstoragedisease;
- phosphoribosylpyrophosphatesynthetase;
- phosphoribosylpyrophosphateamidotransferase;
- adeninephosphoribosyltransferase;
Allopurinolisindicatedforthemanagementof2,8-dihydroxyadenine(2,8-DHA)renalstonesrelatedtodefic
                                
                                Прочитайте повний документ
                                
                            

Сповіщення про пошук, пов’язані з цим продуктом

Переглянути історію документів